🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cancer Risk

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia NCT05727761Phase 22 sites📍 Minneapolis📍 Saint Paul University of Minnesota · Tests: pioglitazone-metformin ABlative Radiotherapy (for) Unfavorable Prostate Tumors NCT04831983n/a1 site📍 Monza University of Milano Bicocca Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site📍 Chicago University of Chicago · Tests: Toripalimab, Carboplatin, Paclitaxel Prostate Tissue BioBank NCT06659614n/a1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer NCT06468332n/a1 site📍 Novara Azienda Ospedaliero Universitaria Maggiore della Carita Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study NCT07640048n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Adebrelimab, Gemcitabine, Cisplatin, S-1, Apatinib Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer NCT04913064NA1 site📍 Duarte City of Hope Medical Center · Tests: Questionnaire Administration, White Button Mushroom Extract A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions NCT07532538n/a1 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia NCT05827549Phase 210 sites📍 Daegu📍 Daejeon📍 Hwasun Ho Joon Im · Tests: Reinduction(4weeks), Cosolodation 1st(3weeks), Consolidation 2nd(3weeks), Blinatumomab 1st(High Risk Group)_4 Weeks, Bl… Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer NCT02971358NA1 site📍 Vienna Medical University of Vienna · Tests: Radical prostatectomy Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma NCT07125755Phase 37 sites📍 Guangzhou📍 Guangzhou📍 Guilin Sun Yat-sen University · Tests: Cisplatin Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention NCT06686108Phase 21 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Azacitidine (AZA) Days 1 - 5, Decitabine (DAC), Venetoclax Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors NCT07095517Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Tirzepatide Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy NCT07104214n/a3 sites📍 Hangzhou📍 Jiaxing📍 Lishui Zhejiang University Precision Medicine in the Prostate Cancer Care Pathway NCT04763317n/a1 site📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Prostate cancer risk gene panel Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse NCT06928662Phase 1, Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy, Chest Radiography, Cytarabine Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT00801489Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cytarabine, Decitabine, Filgrastim-sndz, Fludarabine Phosphate, Gemtuzumab Ozogamicin Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation NCT05945121NA1 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Cardio-oncology program DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome NCT03911297n/a1 site📍 Birmingham Imperial College London · Tests: Women with polycystic ovary syndrome HVA vs IA/DA or VA in the Treatment of ND HR-AML NCT06810791Phase 31 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: HVA, VA, Standard Chemotherapy A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia. NCT06566742Phase 22 sites📍 Miami📍 Houston M.D. Anderson Cancer Center · Tests: Olutasidenib Night-shift Work and Breast Cancer NCT06786949n/a2 sites📍 Bologna📍 Messina IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Questionnaire, Blood samples for biomarker measurement Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort NCT05384535NA1 site📍 Lake Success Northwell Health · Tests: Bi-parametric MRI Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms NCT06063486Phase 22 sites📍 Los Angeles📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-co… Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma NCT07106736Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: BCMA CAR-T, GPRC5D/CD3 BiTEs Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial) NCT07629206NA3 sites📍 Glendale📍 Portland📍 Germantown IceCure Medical Ltd. · Tests: Cryoablation Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) NCT07262957Phase 41 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: HOP bundle Lucid Registry Study NCT05965999n/a1 site📍 Lake Forest Lucid Diagnostics, Inc. · Tests: EsoCheck®, EsoGuard®
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy